Catalyst
Slingshot members are tracking this event:
ContraVir's (CTRV) Phase 2a Data Evaluating Tenofovir Exalidex (TXL) in Patients with Chronic Hepatitis B Virus (HBV) Infection
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CTRV |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 20, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2a, Tenofovir Exalidex, Txl, Chronic Hepatitis B Virus, Hbv
